TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32621262

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) associated with Preventive Oral Care Program (POCP)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Preventive Oral Care Program (POCP) alone
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) associated with POCP
Number of subjects: 48
Study: 32529581

Group type: EXPERIMENTAL
Intervention: Smoking (univariable and multivariable MR analysis)
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI) (univariable and multivariable MR analysis)
Number of subjects: 378
Study: 34315495

Group type: EXPERIMENTAL
Intervention: Lipoprotein(a) levels > 28.72 mg/dL (Q4)
Number of subjects: 9248

Group type: EXPERIMENTAL
Intervention: Lipoprotein(a) levels > 28.72 mg/dL (Q4) among men
Number of subjects: 9248

Group type: EXPERIMENTAL
Intervention: Lipoprotein(a) levels > 28.72 mg/dL (Q4) among individuals age > 60 years
Number of subjects: 9248

Group type: EXPERIMENTAL
Intervention: Lipoprotein(a) levels (Q1 to Q4)
Number of subjects: 9248
Study: 32756916

Group type: EXPERIMENTAL
Intervention: High-sensitivity troponin (hsTn) testing
Number of subjects: 8635
Study: 35085742

Group type: EXPERIMENTAL
Intervention: Shugan granules
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 33971861

Group type: EXPERIMENTAL
Intervention: dr. Bart app
Number of subjects: 214
Study: 37461117

Group type: EXPERIMENTAL
Intervention: Multimodal group (virtual care at home including exercise, nutrition counselling, medication consultation)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Socialization group (once-weekly phone calls)
Number of subjects: 70
Study: 32998148

Group type: EXPERIMENTAL
Intervention: Fingerroot (Boesenbergia rotunda) extract (350 mg extract powder, 3 times daily for 4 weeks)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Fingerroot (Boesenbergia rotunda) extract
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 32067908

Group type: EXPERIMENTAL
Intervention: Partial plaque excision and grafting using Tachosil®
Number of subjects: 21
Study: 35761751

Group type: EXPERIMENTAL
Intervention: Intervention group (group education and telephone coaching)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 30
Study: 34799582

Group type: EXPERIMENTAL
Intervention: CUTseq for high-throughput low-input SCNA profiling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: mfIHC for quantitative immuno-profiling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined analysis of SCNA and immune profiling
Number of subjects: 0
Study: 33333491

Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment (OMT)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Exercise Program (EP)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study: 32352903

Group type: EXPERIMENTAL
Intervention: Serratus anterior plane (SAP) block with 20 mL of 0.2% ropivacaine and 1 μg/mL fentanyl as bolus followed by infusion at 8 mL/h
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Serratus anterior plane (SAP) block
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group received saline for both bolus and infusion
Number of subjects: 50
Study: 36185291

Group type: EXPERIMENTAL
Intervention: Integrated yoga therapy intervention during chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care during chemotherapy
Number of subjects: 0
Study: 33827835

Group type: EXPERIMENTAL
Intervention: Perioperative virtual reality‐based stress reduction exercises twice daily
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Listening to classical music twice daily
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 54
Study: 34956580

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of quick‐acting insulin analogues
Number of subjects: 92
Study: 34898333

Group type: EXPERIMENTAL
Intervention: South Sudan Mental Health Assessment Scale (24-item measure)
Number of subjects: 3137

Group type: EXPERIMENTAL
Intervention: Test-retest reliability assessment
Number of subjects: 3137

Group type: EXPERIMENTAL
Intervention: Concurrent validity assessment
Number of subjects: 3137
Study: 32826102

Group type: EXPERIMENTAL
Intervention: Peer education intervention (two one-hour training sessions on the third day after myocardial infarction)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 70
Study: 36441371

Group type: EXPERIMENTAL
Intervention: Alcohol beverages
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Neutral movie clips
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Erotic movie clips
Number of subjects: 30
Study: 33789403

Group type: EXPERIMENTAL
Intervention: Systematized weaning of opioids for infants with NOWS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32337796

Group type: EXPERIMENTAL
Intervention: Tailored fall prevention education program
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Access to therapy or social supports
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lack of physical and social support
Number of subjects: 30
Study: 33751001

Group type: EXPERIMENTAL
Intervention: Balanced occlusal scheme
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lingualized occlusal scheme
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Monoplane occlusal scheme
Number of subjects: 60
Study: 33472507

Group type: EXPERIMENTAL
Intervention: 0.01% atropine (SA)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Orthokeratology (OK)
Number of subjects: 120
Study: 34669096

Group type: EXPERIMENTAL
Intervention: Letter A (note on family history of breast/ovarian cancer), n=3,402
Number of subjects: 6802

Group type: COMPARATOR
Intervention: Letter B (note with details on possible implications of family history patterns), n=3,200
Number of subjects: 6802

Group type: EXPERIMENTAL
Intervention: Letter B (note with details on possible implications of family history patterns)
Number of subjects: 6802

Group type: COMPARATOR
Intervention: Letter A (note on family history of breast/ovarian cancer)
Number of subjects: 6802

Group type: EXPERIMENTAL
Intervention: In-person consultation offered to women traced by the Genetic Unit (G.U.)
Number of subjects: 6802

Group type: EXPERIMENTAL
Intervention: Testing performed for women who attended the consultation
Number of subjects: 6802
Study: 33772885

Group type: EXPERIMENTAL
Intervention: Extruded feed (EF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pelleted feed (PF)
Number of subjects: 0
Study: 34554369

Group type: EXPERIMENTAL
Intervention: Pictorial warning labels
Number of subjects: 229

Group type: COMPARATOR
Intervention: Text-only cigarette warning
Number of subjects: 229
Study: 32785785

Group type: EXPERIMENTAL
Intervention: Double-lumen irrigation-suction tube
Number of subjects: 761

Group type: COMPARATOR
Intervention: Passive drainage tube
Number of subjects: 761
Study: 36048232

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) set during flexible cystoscopy
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control group (no VR set)
Number of subjects: 270
Study: 33555030

Group type: EXPERIMENTAL
Intervention: Daratumumab, bortezomib and dexamethasone (D‐Vd)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daratumumab monotherapy (after Cycle 8)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bortezomib and dexamethasone (Vd)
Number of subjects: 0
Study: 34315242

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Abdominal Massage
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control
Number of subjects: 91
Study: 34470598

Group type: EXPERIMENTAL
Intervention: BOOST pACP program (three conversation sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 0
Study: 34595983

Group type: EXPERIMENTAL
Intervention: Inebilizumab
Number of subjects: 75
Study: 34263930

Group type: EXPERIMENTAL
Intervention: Prophylactic platelet transfusions
Number of subjects: 0
Study: 33290939

Group type: EXPERIMENTAL
Intervention: Cognitive‐Behavioral Social Skills Training and Compensatory Cognitive Training (CBSST‐CCT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Goal‐Focused Supportive Contact (SC)
Number of subjects: 55
Study: 33008106

Group type: EXPERIMENTAL
Intervention: Hypoxic Pilates Training (HPTG)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Normoxic Pilates Training (NPTG)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 32
Study: 34915741

Group type: EXPERIMENTAL
Intervention: UGN-101 (6 once-weekly instillations via retrograde catheter)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: UGN-101 (maintenance instillations)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: UGN-101 (no maintenance instillations)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: UGN-101 (≥1 maintenance instillation)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: UGN-101
Number of subjects: 71
Study: 33397290

Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 0
Study: 32732703

Group type: EXPERIMENTAL
Intervention: Clinical and technology-based innovations for HSV keratitis management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation of evidence-based medicine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Population-wide disease registries
Number of subjects: 0
Study: 36244331

Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg once daily
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg + Tamsulosin 0.4 mg once daily
Number of subjects: 102
Study: 33814529

Group type: EXPERIMENTAL
Intervention: Change greater than or equal to the median %ΔEPA/AA ratio (Group 2)
Number of subjects: 965

Group type: COMPARATOR
Intervention: Change less than the median %ΔEPA/AA ratio (Group 1)
Number of subjects: 965
Study: 33503851

Group type: EXPERIMENTAL
Intervention: Brain Training with Sulforaphane (BT-S)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Brain Training with Placebo (BT-P)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Active Control Game with Sulforaphane (AT-S)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Active Control Game with Placebo (AT-P)
Number of subjects: 144
Study: 32114612

Group type: EXPERIMENTAL
Intervention: Personalized music (PM)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Slow-tempo music (STM)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Attention control (AC)
Number of subjects: 52
Study: 34794108

Group type: EXPERIMENTAL
Intervention: VVZ‐149 (n = 40)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (n = 20)
Number of subjects: 60
Study: 33481017

Group type: EXPERIMENTAL
Intervention: Multi-omics analysis using transcriptome and/or DNA methylation data from various projects.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Summary-data-based Mendelian randomization approach (SMR).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bonferroni-corrected PSMR < 0.05.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vitro assays for genes DIP2B and SFMBT1.
Number of subjects: 0
Study: 32353906

Group type: EXPERIMENTAL
Intervention: 11 for Health in Denmark intervention (2×45 min/week of football drills and health education for 11 weeks)
Number of subjects: 3061

Group type: EXPERIMENTAL
Intervention: 11 for Health in Denmark intervention
Number of subjects: 3061

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 3061
Study: 35346270

Group type: EXPERIMENTAL
Intervention: MR-guided radiotherapy (MRgRT)
Number of subjects: 82

Group type: COMPARATOR
Intervention: ITV-based stereotactic body radiotherapy (SBRT)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: MRgRT
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Potential prognostic biomarkers
Number of subjects: 82
Study: 33120362

Group type: EXPERIMENTAL
Intervention: Flywheel Inertial Leg Curl (FLC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Nordic Hamstring Exercise (NHE)
Number of subjects: 15
Study: 32098609

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 305

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 305
Study: 35989210

Group type: EXPERIMENTAL
Intervention: Mobile phone intervention
Number of subjects: 248
Study: 34631986

Group type: EXPERIMENTAL
Intervention: Symptom Management Intervention (SMI) with tailored weekly group sessions and mobile health application
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group received routine follow-ups and downloaded the Symptom Management (SM) app
Number of subjects: 61
Study: 35860161

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided Quadratus Lumborum (QL) block
Number of subjects: 136

Group type: COMPARATOR
Intervention: Ultrasound-guided Transversus Abdominis Plane (TAP) block
Number of subjects: 136
Study: 32006994

Group type: EXPERIMENTAL
Intervention: Array Pairing Method (APM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single and dual speaker experiment using APM
Number of subjects: 0
Study: 37052334

Group type: EXPERIMENTAL
Intervention: Buspirone (10 mg orally, three times per day)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 96
Study: 33206270

Group type: EXPERIMENTAL
Intervention: Pregabalin with antioxidants therapy for 8 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 2015754071

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate topical adhesive
Number of subjects: 14

Group type: COMPARATOR
Intervention: Fast absorbing gut suture
Number of subjects: 14
Study: 35954802

Group type: EXPERIMENTAL
Intervention: Experimental condition with accommodation strategies integrated into the HIV prevention session
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard condition (control)
Number of subjects: 20
Study: 32236762

Group type: EXPERIMENTAL
Intervention: Disclosure interview (60-min duration)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control (waitlist)
Number of subjects: 134
Study: 32769505

Group type: EXPERIMENTAL
Intervention: Active nerve block with 20 ml of 0.375% levobupivacaine and clonidine 0.5 μg/kg
Number of subjects: 44

Group type: COMPARATOR
Intervention: Simulated (sham) block only
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Active nerve block
Number of subjects: 44

Group type: COMPARATOR
Intervention: Simulated (sham) block
Number of subjects: 44
Study: 35089370

Group type: EXPERIMENTAL
Intervention: Clinical model using AdaBoost
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Clinical model using LDA
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Clinical model using LR
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Image model using AdaBoost
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Image model using LDA
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Image model using LR
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Combined model using AdaBoost
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Combined model using LDA
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Combined model using LR
Number of subjects: 101
Study: 34034786

Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation (100,000 UI once a month for 6 months)
Number of subjects: 54

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 54
Study: 34626029

Group type: EXPERIMENTAL
Intervention: 25-hour psychosocial support intervention delivered by volunteers
Number of subjects: 48

Group type: COMPARATOR
Intervention: Waiting list (Control Group)
Number of subjects: 48
Study: 33008934

Group type: EXPERIMENTAL
Intervention: Lebrikizumab 250 mg subcutaneously every 4 weeks
Number of subjects: 505

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Combination therapy (Lebrikizumab with pirfenidone)
Number of subjects: 505
Study: 32111310

Group type: EXPERIMENTAL
Intervention: Flattening on floor (FF) housing system
Number of subjects: 168

Group type: COMPARATOR
Intervention: Conventional cage (CC) housing system
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Interaction of housing system and age
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Age of hens
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Both housing systems
Number of subjects: 168
Study: 34983646

Group type: EXPERIMENTAL
Intervention: Screening for abnormal transcranial Doppler (TCD) velocity and initiation of hydroxyurea as standard of care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Efficacy trial for primary prevention of stroke
Number of subjects: 0
Study: 34461211

Group type: EXPERIMENTAL
Intervention: Observational analyses of existing databases
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meta-analysis of multiple studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Causal analysis
Number of subjects: 0
Study: 33233227

Group type: EXPERIMENTAL
Intervention: Yacon syrup (40 g)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (40 g)
Number of subjects: 40
Study: 36375976

Group type: EXPERIMENTAL
Intervention: Nordic hamstring exercise (NHE) program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (regular football training only)
Number of subjects: 0
Study: 33639349

Group type: EXPERIMENTAL
Intervention: Improved pellet quality feed
Number of subjects: 816

Group type: EXPERIMENTAL
Intervention: 20% biochar litter treatment
Number of subjects: 816
Study: 33040103

Group type: EXPERIMENTAL
Intervention: Gallbladder removal with retrieval bag
Number of subjects: 254

Group type: COMPARATOR
Intervention: Gallbladder removal without retrieval bag
Number of subjects: 254
Study: 33419452

Group type: EXPERIMENTAL
Intervention: Robotic partial pancreatoduodenectomy (RPD)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Open partial pancreatoduodenectomy (OPD)
Number of subjects: 80
Study: 32763149

Group type: EXPERIMENTAL
Intervention: Mandibular setback surgery (displacement greater than or equal to 5 mm)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mandibular setback surgery (displacement less than 5 mm)
Number of subjects: 30
Study: 35014593

Group type: EXPERIMENTAL
Intervention: Stiff shoe version
Number of subjects: 41

Group type: COMPARATOR
Intervention: Soft shoe version
Number of subjects: 41
Study: 34534883

Group type: EXPERIMENTAL
Intervention: Genetically determined ACR (urine albumin to creatinine ratio)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Genetically determined SUA (serum uric acid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Genetically determined eGFRcre (estimated glomerular filtration rate based on serum creatinine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Genetically determined eGFRcys (estimated glomerular filtration rate based on serum cystatin C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unweighted polygenic score for ACR
Number of subjects: 0
Study: 34645853

Group type: EXPERIMENTAL
Intervention: Slow deep breathing
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 15
Study: 32753522

Group type: EXPERIMENTAL
Intervention: Novel Floss Holder (NFH)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Novel Floss Holder plus Text Messages (NFH+TM)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Finger Floss (FF)
Number of subjects: 142
Study: 35142425

Group type: EXPERIMENTAL
Intervention: Teleconsultation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Phone consultation
Number of subjects: 20
Study: 34706556

Group type: EXPERIMENTAL
Intervention: MEDI5884 (50, 100, 200, 350, or 500 mg SC)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: MEDI5884 (500 mg SC)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 33683939

Group type: EXPERIMENTAL
Intervention: apalutamide, abiraterone acetate, prednisone and leuprolide (AAPL)
Number of subjects: 118

Group type: COMPARATOR
Intervention: abiraterone, prednisone, leuprolide (APL)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: AAPL and APL (combined)
Number of subjects: 118
Study: 32615798

Group type: EXPERIMENTAL
Intervention: Major amputation in patients with CLI at baseline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Major amputation in patients without CLI at baseline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall major amputation in PAD patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 30-day mortality rate after major amputation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Annual mortality rate following major amputation in CLI at baseline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Annual mortality rate following major amputation in no CLI at baseline
Number of subjects: 0
Study: 35537372

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Strengths training
Number of subjects: 29

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 29

Group type: COMPARATOR
Intervention: Endurance training and Active control condition
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Exercise interventions (Endurance and Strengths)
Number of subjects: 29
Study: 34711976

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 324

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 324
Study: 33200954

Group type: EXPERIMENTAL
Intervention: Lower-cut and scalloped shaft work boot
Number of subjects: 0

Group type: COMPARATOR
Intervention: Higher-cut straight shaft work boot
Number of subjects: 0
Study: 32616158

Group type: EXPERIMENTAL
Intervention: Statin use at baseline
Number of subjects: 18096
Study: 35681264

Group type: COMPARATOR
Intervention: Single immune checkpoint inhibitor (ICI)
Number of subjects: 4665

Group type: COMPARATOR
Intervention: Single ICI plus chemotherapy
Number of subjects: 4665

Group type: COMPARATOR
Intervention: Doublet ICIs
Number of subjects: 4665

Group type: COMPARATOR
Intervention: Single ICI plus radiotherapy
Number of subjects: 4665
Study: 34155332

Group type: EXPERIMENTAL
Intervention: 90 mg/day of baclofen
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 30 mg/day of baclofen
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 120